These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31400276)

  • 21. Impact of Pharmacist-Led Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients With Pneumonia.
    Subedi B; Louzon P; Zappas K; Onyia W; DeBoer K
    Hosp Pharm; 2020 Jun; 55(3):204-210. PubMed ID: 32508359
    [No Abstract]   [Full Text] [Related]  

  • 22. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.
    Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F
    J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis.
    Papp M; Kiss N; Baka M; Trásy D; Zubek L; Fehérvári P; Harnos A; Turan C; Hegyi P; Molnár Z
    Crit Care; 2023 Oct; 27(1):394. PubMed ID: 37833778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of a PCT-based algorithm to guide antibiotic prescription in COPD exacerbation.
    Picart J; Moiton MP; Gaüzère BA; Gazaille V; Combes X; DiBernardo S
    Med Mal Infect; 2016 Dec; 46(8):429-435. PubMed ID: 27609596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of Accepting Infectious Diseases Pharmacist Recommendations: A 5-Year Outcome Study in a Multihospital System.
    Babiarz T; Schmetterer J; Merrick K; Jelic T; Roberts T
    Hosp Pharm; 2024 Jun; 59(3):300-309. PubMed ID: 38765000
    [No Abstract]   [Full Text] [Related]  

  • 26. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis.
    Hohn A; Heising B; Hertel S; Baumgarten G; Hochreiter M; Schroeder S
    Infection; 2015 Aug; 43(4):405-12. PubMed ID: 25588968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.
    Lee CC; Kwa ALH; Apisarnthanarak A; Feng JY; Gluck EH; Ito A; Karuniawati A; Periyasamy P; Pratumvinit B; Sharma J; Solante R; Swaminathan S; Tyagi N; Vu DM; Zirpe K; Schuetz P
    Clin Chem Lab Med; 2020 Nov; 58(12):1983-1991. PubMed ID: 31926074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact on antimicrobial consumption of procalcitonin-guided antibiotic therapy for pneumonia/pneumonitis associated with aspiration in comatose mechanically ventilated patients: a multicenter, randomized controlled study.
    Labro G; Aptel F; Puyraveau M; Paillot J; Pili Floury S; Merdji H; Helms J; Piton G; Ecarnot F; Kuteifan K; Quenot JP; Capellier G;
    Ann Intensive Care; 2021 Oct; 11(1):145. PubMed ID: 34636974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients.
    Goldman JL; Newland JG; Price M; Yu D; Lee BR
    Infect Control Hosp Epidemiol; 2019 Sep; 40(9):968-973. PubMed ID: 31311616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Trials; 2015 Aug; 16():355. PubMed ID: 26272324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of an antimicrobial stewardship program on outcomes in patients with community-acquired pneumonia admitted to a tertiary community hospital.
    Gordon K; Stevens R; Westley B; Bulkow L
    Am J Health Syst Pharm; 2018 Jun; 75(11 Supplement 2):S42-S50. PubMed ID: 29802178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Impact of an Antibiotic Stewardship Program at a Children's Hospital.
    Lee BR; Goldman JL; Yu D; Myers AL; Stach LM; Hedican E; Jackson MA; Newland JG
    Infect Dis Ther; 2017 Mar; 6(1):103-113. PubMed ID: 27913975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
    Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ProCommunity: procalcitonin use in real-world US community hospital settings.
    DeSear KE; Thompson-Leduc P; Kirson N; Chritton JJ; Ie S; Van Schooneveld TC; Cheung HC; Ou S; Schuetz P
    Curr Med Res Opin; 2020 Sep; 36(9):1529-1532. PubMed ID: 32643964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.